Skip to main content
. 2019 Apr 12;30(5):495–500. doi: 10.1097/CAD.0000000000000758

Fig. 4.

Fig. 4

The concentration of MMP9 was significantly decreased in the T0901317 and gefitinib combination group. *P<0.05.